IP Library Granted Patent US 10,876,090
Granted Patent B2
US 10,876,090 · App. 15/938,800 · Granted Dec 29, 2020

Cell growth matrix

Inventors: José Castillo (Brussels, BE); Bastien Mairesse (Uccle, BE); Quentin Vanwalleghem (Uccle, BE)
Assignee: UNIVERCELLS TECHNOLOGIES S.A.
C12M25/14C12M1/18C12M23/06C12M23/22C12M23/28C12M23/44C12M25/02C12M25/06C12M25/16C12M41/46C12N5/0068C12N5/06C12N2533/90C12N2535/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,876,090
App. No.
15/938,800
Granted
Dec 29, 2020
Kind
B2
Abstract

The invention provides a structured cell growth matrix or assembly comprising a one or more spacer layers and one or more cell immobilization layers. The invention further provides a bioreactor comprising said matrix or assembly.

Claims (24)

1. A cell growth matrix assembly comprising a spiral configuration including a plurality of cell immobilization layers, each having a surface which allows cells to adhere and grow, and a plurality of spacer layers, each containing a tortuous path producing structure adjacent to each of said cell immobilization layers, and forming a channel allowing passage of cells and medium along the surface of the plurality of cell immobilization layers, the tortuous path producing structure of each spacer layer adapted to direct the cells into the one or more cell immobilization layers and adhere at a depth therein,

wherein said plurality of cell immobilization layers are made of a woven or nonwoven fabric;

wherein the cell growth matrix assembly includes an open central portion including a core about which the plurality of spacer layers and the plurality of cell immobilization layers are positioned;

wherein at least one of the plurality of spacer layers is unattached to an adjacent one of the plurality of cell immobilization layers;

wherein the cell growth matrix assembly comprises an innermost spacer layer and an outermost spacer layer; and

wherein a thickness ratio of at least one of the plurality of cell immobilization layers to at least one of the plurality of spacer layers is between 1:2 and 2:1.

2. The cell growth matrix assembly of claim 1 , wherein a thickness ratio of at least one of the plurality of cell immobilization layers to at least one of the plurality of spacer layers is 2:1.

3. The cell growth matrix assembly of claim 1 , wherein a thickness of each of the plurality of spacer layers is between 0.05 mm and 3 mm.

4. The cell growth matrix assembly of claim 1 , wherein a thickness of each of the plurality of cell immobilization layers is between 0.05 mm and 3 mm.

5. Cell growth matrix assembly according to claim 1 , wherein each spacer layer contains a mesh structure.

6. Cell growth matrix assembly according to claim 5 , characterized in that the each spacer layer has a mesh size of between 0.05 mm to 5 mm.

7. Cell growth matrix assembly of claim 1 , wherein at least two cell immobilization layers are in contact between at least two spacer layers of the plurality of spacer layers.

8. The cell growth matrix assembly of claim 1 , wherein the plurality of cell immobilization layers are made of a biocompatible polymer selected from the group consisting of polyester, polyethylene, polypropylene, polyamide, plasma treated polyethylene, plasma treated polyester, plasma treated polypropylene or plasma treated polyamide.

9. The cell growth matrix assembly of claim 1 , wherein the plurality of spacer layers are made of a biocompatible polymer selected from the group consisting of polyester, polyethylene, polypropylene, polyamide, plasma treated polyethylene, plasma treated polyester, plasma treated polypropylene or plasma treated polyamide.

10. The cell growth matrix assembly of claim 1 , wherein the plurality of cell immobilization layers are hydrophilic.

11. The cell growth matrix assembly of claim 1 , wherein the plurality of spacer layers are hydrophilic.

12. The cell growth matrix assembly of claim 1 , wherein at least one surface of each immobilization layer is in contact with one surface of at least one spacer layer.

13. The cell growth matrix assembly of claim 1 , wherein each spacer layer creates a channel allowing passage of cells and medium along a surface of an adjacent cell immobilization layer.

14. A bioreactor comprising a cell growth matrix assembly as described in claim 1 .

15. The bioreactor of claim 14 , further including a housing having therein an outer chamber for receiving the cell growth matrix assembly and an inner chamber located within the open central portion of the cell growth matrix assembly.

16. The bioreactor according to claim 14 having an inner space and wherein the cell growth matrix assembly represents at least 10% and at most 90% of said inner space.

17. The bioreactor according to claim 14 , wherein the bioreactor and/or the cell growth matrix assembly are single use.

18. The bioreactor of claim 14 , wherein the bioreactor is adapted to cause flow through the matrix assembly in an axial direction from bottom to top.

19. The bioreactor of claim 14 , wherein the bioreactor is adapted to cause flow through the matrix assembly in an axial direction from top to bottom.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2020
From: UNIVERCELLS S.A.
To: UNIVERCELLS TECHNOLOGIES S.A.
Reel/Frame 052682/0697 →
RELEASE OF SECURITY INTEREST Recorded Mar 12, 2020
From: EUROPEAN INVESTMENT BANK
To: UNIVERCELLS SA
Reel/Frame 052098/0631 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2019
From: CASTILLO, JOSE; MAIRESSE, BASTIEN; VANWALLEGHEM, QUENTIN
To: UNIVERCELLS NV
Reel/Frame 050731/0488 →
SECURITY INTEREST Recorded Oct 14, 2019
From: UNIVERCELLS SA
To: EUROPEAN INVESTMENT BANK
Reel/Frame 050716/0598 →
Priority Claims (1)
BE 2016/5839 · Nov 9, 2016 · national
Continuity (2)
Continuation PCTEP2017078775 · Nov 9, 2017
Related Publication 20180282678A1 · Oct 4, 2018
Cited By (1)
US 12,454,670